Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL

Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL

New York, Jan 14, 2026, 07:34 EST — Premarket

  • Shares of Allstate dropped 5.3%, ending Tuesday at $197.65. (Yahoo Finance)
  • CEO Thomas Wilson offloaded roughly $3.49 million in shares, following a pre-arranged trading plan, according to a recent filing. (Investing.com Canada)
  • TD Cowen downgraded Allstate from “buy” to “hold,” but raised its price target to $231. (Benzinga)

Shares of Allstate dropped 5.28% on Tuesday, closing at $197.65 on a volume near 4.46 million, per data from the company’s investor site. (Allstateinvestors)

The decline comes as Allstate approaches its next earnings report in early February, a key event that could shift outlooks on underwriting and investment returns. The insurer is set to release fourth-quarter results on Feb. 5, with the filing expected the day before. (Nasdaq)

Rate bets remain in focus. Tuesday’s U.S. inflation figures kept traders guessing on the timing of the next Federal Reserve cut, pushing Treasury yields slightly lower after the release. (Reuters)

A regulatory filing late Tuesday revealed that Chief Executive Thomas Wilson offloaded 16,807 shares on Jan. 12. The sale occurred under a Rule 10b5-1 trading plan established on June 27, 2025. (SEC)

A 10b5-1 plan is a pre-set trading arrangement allowing insiders to sell shares on a fixed timetable, shielding those transactions from daily news noise. On its own, it doesn’t reveal an executive’s stance on the stock.

TD Cowen cut Allstate to “hold” from “buy” on Monday but bumped up its price target to $231 from $224, according to a report outlining the note. (GuruFocus)

Tuesday’s drop at Allstate wasn’t unique in the insurance space. Progressive slid 5.25%, with Travelers and Chubb also retreating 3.30% and 1.94%, respectively, according to their most recent closing prices.

Catastrophe risk continues to simmer for property insurers, despite the spotlight often on ratings and insider trades. Munich Re reported that global insured losses from natural disasters hit $108 billion in 2025, cautioning that “a warming world makes extreme weather disasters more likely.” (Reuters)

The near-term risk remains straightforward: if claims trends or weather losses take a turn for the worse as the quarter ends, or if yields continue to fall, insurers could see their gains vanish fast after a solid rally.

Allstate is set to release its fourth-quarter earnings after 4:15 p.m. ET on Feb. 4, with a conference call scheduled for 9 a.m. ET on Feb. 5. (Allstatenewsroom)

Stock Market Today

  • Novavax jumps 11.9% on Cantor Fitzgerald upgrade; eyes on 2025 sales and Matrix-M potential
    January 14, 2026, 10:14 AM EST. Novavax NVAX jumped 11.9% in the last session, closing at $8.67 on stronger-than-average volume. The move followed reports that Cantor Fitzgerald reiterated an Overweight rating with a $18 target, more than double the current price. Cantor sees 2025 sales improving as Nuvaxovid gains momentum under Sanofi's commercial leadership, and views Novavax's Matrix-M vaccine platform as a long-term asset. The stock also climbed after a four-week run of about 17.8%. Analysts expect a quarterly loss of $0.66 per share (EPS = earnings per share) and revenue of $78.41 million, down 11.2% year over year. A higher or lower revision in earnings estimates often moves prices in the near term, and Novavax currently has a Zacks Rank #3 (Hold). Ocugen, in the same space, rose 7.3%.
Rockwool stock steadies today after Russia takeover shock — buyback and February report now in focus
Previous Story

Rockwool stock steadies today after Russia takeover shock — buyback and February report now in focus

Mastercard stock steadies in premarket as Trump’s 10% credit-card cap talk keeps MA in focus
Next Story

Mastercard stock steadies in premarket as Trump’s 10% credit-card cap talk keeps MA in focus

Go toTop